Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Royer

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Blood|March 23, 2016
VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trialPhilippe Moreau, Cyrille Hulin, Margaret Macro, et al.
Blood|September 26, 2018
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myelomaAurore Perrot, Valerie Lauwers-Cances, Jill Corre, et al.
Blood|May 5, 2022
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 studyMurielle Roussel, Valérie Lauwers-Cances, Margaret Macro, et al.
Nature Medicine|June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trialXavier Leleu, Cyrille Hulin, Jerome Lambert, et al.
Haematologica|April 26, 2014
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopeniaPatrizia Noris, Nicole Schlegel, Catherine Klersy, et al.
Leukemia|April 11, 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Maxime Vallée, Xiaomu Wei, et al.
Journal of Clinical Immunology|August 12, 2019
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary ImmunodeficiencyHélène Coignard-Biehler, Nizar Mahlaoui, Benoit Pilmis, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Blood|March 23, 2016
VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trialPhilippe Moreau, Cyrille Hulin, Margaret Macro, et al.
Blood|September 26, 2018
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myelomaAurore Perrot, Valerie Lauwers-Cances, Jill Corre, et al.
Blood|May 5, 2022
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 studyMurielle Roussel, Valérie Lauwers-Cances, Margaret Macro, et al.
Nature Medicine|June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trialXavier Leleu, Cyrille Hulin, Jerome Lambert, et al.
Haematologica|April 26, 2014
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopeniaPatrizia Noris, Nicole Schlegel, Catherine Klersy, et al.
Leukemia|April 11, 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Maxime Vallée, Xiaomu Wei, et al.
Journal of Clinical Immunology|August 12, 2019
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary ImmunodeficiencyHélène Coignard-Biehler, Nizar Mahlaoui, Benoit Pilmis, et al.
Pageof 11